ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

DCBDC Board Cool to Proposals On Study Sections

November 23, 1990

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

NCI To Offer New Grants In Preventative Oncology -Epidemiology, Biostatistics

October 26, 1979

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

DeVita’s Appointment Reportedly On Carter’s Desk, May Be Made Official By End Of Month

May 9, 1980

HIPAA Interpretations Vary, Delay Research, ASCO Study Finds

July 31, 2009